Click
here
to review the New Year operating hours.
x
Dubai Health and Boston Children's Hospital Sign Memorandum of Understanding to Advance Pediatric Care
21 Nov 2025
Dubai, UAE, November 2025: In recognition of World Children's Day, Boston Children's Hospital, one of the world's leading pediatric academic health centers, and Dubai Health have signed a Memorandum of Understanding (MOU), reflecting their shared commitment to elevating children’s health and supporting patient care through clinical excellence, education, research, and philanthropy.
The MOU was signed by Dr. Ryan Nagy, MD, MBA, President and Chief Operating Officer of Boston Children's Hospital, and Dr. Mohamed Al Awadhi, Executive Director of the Dubai Health Women and Children's Campus, which includes Al Jalila Children's Hospital, Latifa Hospital, and the Dubai Fertility Centre. The agreement establishes a collaborative framework that will guide joint efforts to strengthen pediatric services across Dubai Health's network.
The Boston Children’s Hospital delegation included Dr. Ryan Nagy, MD, MBA, President and Chief Operating Officer, Christopher R. Viney, JD, Executive Vice President, System General Counsel; John G. Meara, MD, DMD, MBA, Professor of Surgery, Harvard Medical School; Diala Atassi, MBA, Vice President- Global Alliances; Michelle Niescierenko MD, MPH, Director Global Health Program.
The delegation was received by His Excellency Dr. Amer Sharif, CEO of Dubai Health, as well as Dr. Hanan AlSuwaidi, Deputy CEO and Chief Academic Officer; Dr. Muna Tahlak, Chief Medical Officer; Dr. Tarek Fathey, Chief Clinical Officer; Dr. Mohamed Al Awadhi, Executive Director of the Dubai Health Women and Children's Campus, and Atif Albraiki, Chief Digital and AI Officer.
Dr. Ryan Nagy, MD, MBA, Boston Children's Hospital President and Chief Operating Officer, said, "Boston Children's Hospital is proud to join forces with Dubai Health in a shared commitment to support pediatric care, education, and research. Together, we are committed to supporting the health system's mission to deliver exceptional outcomes for children and families in the region."
Dr. Mohamed Al Awadhi, Executive Director of the Dubai Health Women and Children's Campus, said: "We are grateful for this partnership with Boston Children's Hospital, a globally recognized leader in pediatric care and treatment. This collaboration strengthens key initiatives across our integrated academic health system by enhancing the quality of care for children, expanding training for clinicians and students, advancing research and innovation, and reinforcing our commitment to giving through meaningful programs. We look forward to working together to improve pediatric health, deliver better outcomes for children and their families across the region, and further our vision to advance health for humanity."
The visit also provided the Boston Children's Hospital delegation with an opportunity to learn more about Dubai Health's integrated academic health system and to explore potential future collaborations across clinical services, education, research, and philanthropy. Both organizations affirmed their commitment to building a long-term partnership that supports the advancement of pediatric healthcare in Dubai and contributes to the broader global effort to improve outcomes for children everywhere.
DNDI and Dubai Health Sign a Partnership to Advance Research and Training in Neglected Diseases
Dubai Health has signed a Memorandum of Understanding (MoU) with the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) at World Health Expo Dubai (WHX).
The agreement was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences, and Dr. Luis Pizarro, Executive Director of the Drugs for Neglected Diseases initiative (DNDi), in the presence of His Excellency Nicolas Niemtchinow, Ambassador of France to the UAE, and Thi Hanh Cao, Director of External Relations at DNDi.
The partnership establishes a framework for collaboration in medical education, research, and clinical training, with a shared goal of improving health outcomes for underserved populations affected by neglected infectious diseases. It brings together DNDi’s global expertise in needs‑driven drug discovery and development and Dubai Health’s integrated academic health system to support research and capacity‑building across priority global health areas.
Under the agreement, students from Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health will take part in DNDi‑led programs, including fieldwork and clinical research activities in Africa and Asia. These programs provide hands‑on exposure to patients affected by neglected diseases and to the full spectrum of drug discovery, development and public health delivery. DNDi experts will also contribute to MBRU academic programs, supporting two‑way academic and professional exchange.
The collaboration will begin with joint research scoping to identify priority projects. It will involve active faculty engagement through guest lectures, curriculum development, student co‑supervision, joint grant applications, and collaborative research publications.
The partnership will also encompass collaboration in drug discovery, clinical trials, regulatory science, and public health policy, with a particular focus on viral diseases, pandemic preparedness, and fungal infections. In addition, it will support joint initiatives in the application of artificial intelligence to health research, as well as the co‑organization of scientific conferences and workshops and the dissemination of knowledge on key global health challenges.
Dr. Luis Pizarro, said: “Neglected diseases disproportionately affect the world’s most vulnerable populations and are often overlooked by traditional research models. Through this partnership with Dubai Health, we aim to advance scientific progress while helping train the next generation of global health leaders to deliver more equitable health solutions.”
Dr. Hanan AlSuwaidi, said: “This partnership represents a meaningful step forward in how we prepare our students and researchers to engage with the world’s most pressing and complex health challenges. By partnering with DNDi, we are giving our learners direct access to real-world drug development, clinical research, and global health practice. It reflects our commitment to advancing health for humanity by ensuring that care, learning, discovery, and giving are driven by purpose and real-world impact.”